Get the Stockscreener App
11.09
2.50%
0.27
Lensar Inc stock is traded at $11.09, with a volume of 52,012.
It is up +2.50% in the last 24 hours and up +28.21% over the past month.
LENSAR Inc is a commercial-stage medical device company focused on designing, developing and marketing a femtosecond laser system for the treatment of cataracts. The company Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency and reproducibility by providing imaging, simplified procedure planning, efficient design and precision. Its product portfolio consists of the LENSAR Laser System with Streamline IV and IntelliAxis and its associated consumable components. The consumable portion of the system consists of a disposable patient interface device, or PID, kit and a procedure license. Each procedure on each system requires the use of a PID kit.
See More
Previous Close:
$10.82
Open:
$10.91
24h Volume:
52,012
Relative Volume:
0.77
Market Cap:
$125.67M
Revenue:
$42.16M
Net Income/Loss:
$-14.38M
P/E Ratio:
-6.1955
EPS:
-1.79
Net Cash Flow:
$-9.90M
1W Performance:
-0.09%
1M Performance:
+28.21%
6M Performance:
+150.34%
1Y Performance:
+131.04%
1-Day Range:
$10.41
$11.25
1-Week Range:
$10.08
$12.13
52-Week Range:
$2.67
$12.13
Lensar Inc Stock (LNSR) Company Profile
Name
Lensar Inc
Sector
Industry
Phone
888-536-7271
Address
2800 DISCOVERY DRIVE, ORLANDO
Compare LNSR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LNSR
Lensar Inc
|
11.09 | 125.67M | 42.16M | -14.38M | -9.90M | -1.79 |
|
ABT
Abbott Laboratories
|
129.06 | 222.39B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
105.61 | 154.78B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
392.90 | 150.99B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.01 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
71.06 | 41.87B | 6.60B | 4.16B | 490.10M | 6.93 |
Lensar Inc Stock (LNSR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-24-21 | Initiated | SVB Leerink | Outperform |
Lensar Inc Stock (LNSR) Latest News
Navigating the Volatility of LENSAR Inc’s (LNSR) Stock - The News Heater
Medical Devices Firm Lensar Surges Ahead On Robotic Technology (NASDAQ:LNSR) - Seeking Alpha
LENSAR reports inducement grants - Medical Buyer
LENSAR Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewswire
LENSAR Awards Strategic Employee Stock Options: Key Details Revealed - StockTitan
(LNSR) On The My Stocks Page - Stock Traders Daily
Even With A 28% Surge, Cautious Investors Are Not Rewarding LENSAR, Inc.'s (NASDAQ:LNSR) Performance Completely - Simply Wall St
LENSAR, Inc.'s (NASDAQ:LNSR) Profit Outlook - Simply Wall St
LENSAR, Inc. (NASDAQ:LNSR) surges 13%; retail investors who own 40% shares profited along with institutions - Yahoo Finance
LENSAR Stock Soars to 52-Week High, Reaching $9.25 - MSN
LENSAR Stock Soars to 52-Week High, Reaching $9.25 By Investing.com - Investing.com South Africa
(LNSR) Investment Analysis - Stock Traders Daily
Geode Capital Management LLC Raises Position in LENSAR, Inc. (NASDAQ:LNSR) - Defense World
Trading (LNSR) With Integrated Risk Controls - Stock Traders Daily
Paradigm Medical Industries (OTCMKTS:PDMI) vs. LENSAR (NASDAQ:LNSR) Head-To-Head Analysis - Defense World
LENSAR announces inducement grants - Medical Buyer
LENSAR Grants Stock Options to New Employees Under Inducement Award Plan - StockTitan
(LNSR) Proactive Strategies - Stock Traders Daily
Sanctuary Advisors LLC Sells 1,439 Shares of LENSAR, Inc. (NASDAQ:LNSR) - Defense World
We're Hopeful That LENSAR (NASDAQ:LNSR) Will Use Its Cash Wisely - Simply Wall St
LENSAR Stock Soars to 52-Week High, Reaching $8.20 - Investing.com India
LENSAR, Inc.'s (NASDAQ:LNSR) Path To Profitability - Yahoo Finance
Contrasting LENSAR (NASDAQ:LNSR) and Quipt Home Medical (NASDAQ:QIPT) - Defense World
LENSAR (NASDAQ:LNSR) Stock Price Up 0.9%Here's What Happened - MarketBeat
(LNSR) Pivots Trading Plans and Risk Controls - Stock Traders Daily
LENSAR Awards Stock Options to New Employees in Key Talent Acquisition Move - StockTitan
LENSAR to Participate in the BTIG 4th Annual Ophthalmology Day - Marketscreener.com
LENSAR CEO to Present at BTIG Ophthalmology Conference, Discuss Laser Cataract Innovation | LNSR Stock News - StockTitan
LENSAR Stock Soars to 52-Week High, Hits $8 Mark By Investing.com - Investing.com Canada
LENSAR Stock Soars to 52-Week High, Hits $8 Mark - Investing.com India
Small Cap Tech Stock Soars On University Order Announcement - The Globe and Mail
Sintx Technologies (NASDAQ:SINT) vs. LENSAR (NASDAQ:LNSR) Head-To-Head Contrast - Defense World
LENSAR, Inc. (NASDAQ:LNSR) Sees Significant Decrease in Short Interest - MarketBeat
LENSAR, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Park West Asset Management LLC's Strategic Acquisition in LENSAR Inc - GuruFocus.com
LENSAR, Inc. (NASDAQ:LNSR) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: LENSAR reports strong Q3 growth, eyes continued expansion By Investing.com - Investing.com South Africa
Earnings call: LENSAR reports strong Q3 growth, eyes continued expansion - Investing.com
LENSAR Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance
LENSAR stock soars to 52-week high, hits $6.4 amid robust growth - Investing.com Australia
LENSAR shares rise as BTIG lifts target to $10 on strong Q3 results - Investing.com Australia
(LNSR) Trading Signals - Stock Traders Daily
LENSAR Inc (LNSR) Q3 2024 Earnings Call Highlights: Record Reven - GuruFocus.com
Lensar Inc Stock (LNSR) Financials Data
Revenue
Net Income
Cash Flow
EPS
Lensar Inc Stock (LNSR) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Winer Gary M | Director |
Aug 28 '24 |
Buy |
4.45 |
1,000 |
4,450 |
80,155 |
| Winer Gary M | Director |
Aug 26 '24 |
Buy |
4.58 |
802 |
3,673 |
78,655 |
| Winer Gary M | Director |
Aug 27 '24 |
Buy |
4.50 |
500 |
2,250 |
79,155 |
| Winer Gary M | Director |
Aug 21 '24 |
Buy |
4.35 |
500 |
2,176 |
77,851 |
| Winer Gary M | Director |
Aug 22 '24 |
Buy |
4.30 |
2 |
9 |
77,853 |
| Winer Gary M | Director |
Aug 20 '24 |
Buy |
4.20 |
500 |
2,100 |
77,351 |
| Winer Gary M | Director |
Aug 16 '24 |
Buy |
4.03 |
6 |
24 |
76,851 |
| Winer Gary M | Director |
Aug 14 '24 |
Buy |
4.20 |
1,000 |
4,200 |
76,845 |
| Winer Gary M | Director |
Aug 12 '24 |
Buy |
4.03 |
500 |
2,015 |
75,845 |
| STAAB THOMAS R II | Chief Financial Officer |
Aug 08 '24 |
Option Exercise |
2.65 |
3,500 |
9,275 |
162,434 |
1.21%
0.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):